Patients with metabolic disorders frequently suffer from side effects induced by long-term oral medications. The present study using a rat model system indicated that leflunomide (LF) and amlodipine (AMD), the active ingredients contained in the medications for rheumatoid arthritis and hypertension, respectively, appeared to induce various bowel problems including constipation and inflammation. In the small and large intestine, LF increased the expression of tumour necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 compared to the null control and AMD increased the expression of both TNF-α and IL-1β, although its effect on IL-6 was only increased in the large intestine. It is noteworthy that the probiotic blend tested was found to alleviate intestinal complications caused by LF and AMD. Analysis of the gut microbiota revealed that AMD induced compositional changes in the gut microbiota. Namely, members of the phylum Bacteroidetes, which constituted only about 0.3% of the microbiota in the null control, made up more than 10% of the total composition in the AMD-administered rats. Interestingly, the probiotic blend was also found to normaliSe the gut microbiota.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
Althani, A.A., Marei, H.E., Hamdi, W.S., Nasrallah, G.K., El Zowalaty, M.E., Al Khodor, S., Al-Asmakh, M., Abdel-Aziz, H. and Cenciarelli, C., 2016. Human microbiome and its association with health and diseases. Journal of Cellular Physiology 231: 1688-1694.
'Human microbiome and its association with health and diseases ' () 231 Journal of Cellular Physiology : 1688 -1694.
Awadel-Kariem,F.M., Patel, P., Kapoor, J., Brazier, J.S. and Goldstein, E.J.C., 2010. First report of Parabacteroides goldsteinii bacteraemia in a patient with complicated intra-abdominal infection. Anaerobe 16: 223-225.
'First report of Parabacteroides goldsteinii bacteraemia in a patient with complicated intra-abdominal infection ' () 16 Anaerobe : 223 -225.
Beidler, S.K., Douillet, C.D., Berndt, D.F., Keagy, B.A., Rich, P.B. and Marston, W.A., 2009. Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. Journal of Vascular Surgery 49:1013-1020.
'Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy ' () 49 Journal of Vascular Surgery : 1013 -1020.
Byun, S.J., Lim, T.J., Lim, Y.J., Seo, J.G. and Chung, M.J., 2016. In vivo effects of s-pantoprazole, polaprenzinc, and probiotic blend on chronic small intestinal injury induced by indomethacin. Beneficial Microbes 7: 731-737.
'In vivo effects of s-pantoprazole, polaprenzinc, and probiotic blend on chronic small intestinal injury induced by indomethacin ' () 7 Beneficial Microbes : 731 -737.
Carding, S., Verbeke, K., Vipond, D.T., Corfe, D.M. and Owen, L.J., 2015. Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health and Disease 26: 26191.
'Dysbiosis of the gut microbiota in disease ' () 26 Microbial Ecology in Health and Disease : 26191.
Chassard, C., Dapoigny, M., Scott, K.P., Crouzet, L., Del’homme, C., Marquet, P., Martin, J.C., Pickering, G., Ardid, D., Eschalier, A., Dubray, C., Flint, H.J. and Bernalier-Donadile, A., 2012. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 35: 828-838.
'Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome ' () 35 Alimentary Pharmacology and Therapeutics : 828 -838.
Cohen, S., Cannon, G.W., Schiff, M., Weaver, A., Fox, R., Olsen, N., Furst, D., Sharp, J., Moreland, L., Caldwell, J., Kaine, J. and Strand, V., 2001. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Arthritis and Rheumatism 44: 1984-1992.
'Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate ' () 44 Arthritis and Rheumatism : 1984 -1992.
Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., Sokol, H., Coffin, B. and Sabate, J.M., 2012. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterology and Motility 24: 513-520.
'Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome ' () 24 Neurogastroenterology and Motility : 513 -520.
Gill, S.R., Pop, M., DeBoy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., Gordon, J.I., Relman, D.A., Fraser-Liggett, C.M. and Nelson, K.E., 2006. Metagenomic analysis of the human distal gut microbiome. Science 312: 1355-1359.
'Metagenomic analysis of the human distal gut microbiome ' () 312 Science : 1355 -1359.
Guinane, C.M. and Cotter, P.D., 2013. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therapeutic Advances in Gastroenterology 6: 295-308.
'Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ ' () 6 Therapeutic Advances in Gastroenterology : 295 -308.
Kverka, M., Zakostelska, Z., Klimesova, K., Sokol, D., Hudcovic, T., Hrncir, T., Rossmann, P., Mrazek, J., Kopecny, J., Verdu, E.F. and Tlaskalova-Hogenova, H., 2011. Oral administration of Parabacteroidesdistasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clinical and Experimental Immunology 163: 250-259.
'Oral administration of Parabacteroidesdistasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition ' () 163 Clinical and Experimental Immunology : 250 -259.
Kwak, D.S., Jun, D.W., Seo, J.G., Chung, W.S., Park, S.-E., Lee, K.N., Khalid-Saeed, W., Lee, H.L., Lee, O.Y. and Yoon, B.C., 2014. Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease. European Journal of Gastroenterology and Hepatology 26: 1353-1359.
'Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease ' () 26 European Journal of Gastroenterology and Hepatology : 1353 -1359.
Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D. and Gordon, J.I., 2005. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the USA 102: 11070-11075.
'Obesity alters gut microbial ecology ' () 102 Proceedings of the National Academy of Sciences of the USA : 11070 -11075.
Marchesi, J.R., Adams, D.H., Fava, F., Hermes, G.D.A., Hirschfield, G.M., Hold, G., Quraishi, M.N., Kinross, J., Smidt, H., Tuohy, K.M., Thomas, L.V., Zoetendal, E.G. and Hart, A., 2016. The gut microbiota and host health: a new clinical frontier. Gut 65: 330-339.
'The gut microbiota and host health: a new clinical frontier ' () 65 Gut : 330 -339.
Mazmainan, S.K., Liu, C.H., Tzianabos, A.O. and Kasper, D.L., 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of host immune system. Cell 122: 107-118.
'An immunomodulatory molecule of symbiotic bacteria directs maturation of host immune system ' () 122 Cell : 107 -118.
Mondot, S., Kang, S., Furet, J.P., Aguirre de Carcer, D., McSweeney, C., Morrison, M., Marteau, P., Dore, J. and Leclerc, M., 2011. Highlighting new phylogenetic specificities of Crohn’s disease microbiota. Inflammatory Bowel Disease 17: 185-192.
'Highlighting new phylogenetic specificities of Crohn’s disease microbiota ' () 17 Inflammatory Bowel Disease : 185 -192.
Ridlon, J.M., Alves, J.M., Hylemon, P.B. and Bajaj, J.S., 2013. Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship. Gut Microbes 4: 382-387.
'Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship ' () 4 Gut Microbes : 382 -387.
Sevilla, M.A., Voces, F., Carrón, R., Guerrero, E.I., Ardanaz, N., San Román, L., Arévalo, M.A. and Montero, M.J., 2004. Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal. Life Science 75: 881-889.
'Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal ' () 75 Life Science : 881 -889.
Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J.P., Letulle, S., Langella, P., Corthier, G., Tran Van Nhieu, J. and Furet, J.P., 2011. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 6: e16393.
'Microbial dysbiosis in colorectal cancer (CRC) patients ' () 6 PLoS ONE : e16393.
White, W.B., Duprez, D., St Hillaire, R., Krause, S., Roniker, B., Kuse-Hamilton, J. and Weber, M.A., 2003. Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension. Hypertension 41: 1021-1026.
'Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension ' () 41 Hypertension : 1021 -1026.
Yamaguchi, T., Kakefuda, R., Tanimoto, A., Watanabe, Y. and Tajima, N., 2012. Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide. Inflammation Research 61: 445-454.
'Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide ' () 61 Inflammation Research : 445 -454.
Yoon, J.S., Sohn, W., Lee, O.Y., Lee, S.P., Lee, K.N., Jun, D.W., Lee, H.L., Yoon, B.C., Choi, H.S and Chung, W.S., 2014. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Journal of Gastroenterology and Hepatology 29: 52-59.
'Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial ' () 29 Journal of Gastroenterology and Hepatology : 52 -59.
Zhang, J.M. and An, J., 2007. Cytokines, inflammation and pain. International Anesthesiology Clinics 45: 27-37.
'Cytokines, inflammation and pain ' () 45 International Anesthesiology Clinics : 27 -37.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 675 | 234 | 16 |
| Full Text Views | 17 | 4 | 1 |
| PDF Views & Downloads | 25 | 9 | 4 |
Patients with metabolic disorders frequently suffer from side effects induced by long-term oral medications. The present study using a rat model system indicated that leflunomide (LF) and amlodipine (AMD), the active ingredients contained in the medications for rheumatoid arthritis and hypertension, respectively, appeared to induce various bowel problems including constipation and inflammation. In the small and large intestine, LF increased the expression of tumour necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 compared to the null control and AMD increased the expression of both TNF-α and IL-1β, although its effect on IL-6 was only increased in the large intestine. It is noteworthy that the probiotic blend tested was found to alleviate intestinal complications caused by LF and AMD. Analysis of the gut microbiota revealed that AMD induced compositional changes in the gut microbiota. Namely, members of the phylum Bacteroidetes, which constituted only about 0.3% of the microbiota in the null control, made up more than 10% of the total composition in the AMD-administered rats. Interestingly, the probiotic blend was also found to normaliSe the gut microbiota.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 675 | 234 | 16 |
| Full Text Views | 17 | 4 | 1 |
| PDF Views & Downloads | 25 | 9 | 4 |